Navigation Links
Sanomedics International Holdings, Inc. appoints new Chairman of the Board and installs new Director of Business Development.
Date:9/11/2013

MIAMI, Sept. 11, 2013 /PRNewswire/ -- Sanomedics International Holdings, Inc. (OTCQB: SIMH), a Miami based medical technology holding Company that focuses on game changing products, services and ideas, announces that William Lerner, Esq., a board member of the Company since March 2013, has been appointed to serve as the chairman of the executive board of the Company.

Keith Houlihan, Co-founder and President of Sanomedics, stated, "We are fortunate to have someone of Mr. Lerner's caliber as our Chairman. Mr. Lerner will help position us for a listing upgrade and strengthen our corporate governance requirements. He will serve the best interests of the company during this time of growth and we look forward to working with Mr. Lerner."

Mr. Lerner, a graduate of Cornell University and of the New York University School of Law, is a member of the bars of New York and Pennsylvania, with a Peer Rating for more than 25 years of AV (Martindale Hubbell). For over the last five years, Mr. Lerner has been engaged in the private practice of corporate and securities law in New York and Pennsylvania. Since 2006, Mr. Lerner has served as a director/trustee of The Daily Income Fund, a diversified, open-end management investment company, and also serves as the Chairman of the Compliance and Risk Committee. Mr. Lerner also served as Branch Chief of the Enforcement Division at the SEC and a former officer and director of compliance at the American Stock Exchange.

Mr. Lerner is also a director of National Holdings Corporation, a holding company for National Securities Corporation, vFinance Investments, Inc., National Asset Management, Inc. and National Insurance Corporation. National Securities and vFinance are broker-dealers registered with the Securities and Exchange Commission, and members of FINRA and SIPC. National Asset Management is an SEC registered investment adviser, and National Insurance provides a full array of fixed insurance products.

Additionally the Company announces the promotion of Mr. Mark Miklos as General Manager and Director of Business Development for the newly acquired company Prime Time Medical.

"Mark is bringing more than 20+ years of building healthcare businesses, a proven ability to create and pursue new markets", stated Keith Houlihan, Co-founder and President of Sanomedics. "Having Mark will be a valuable asset to the Sanomedics family as we look to expand our market presence through organic and acquired growth."

Mark was the founder and President of Prime Time Medical Inc. since 2009 up to the recent purchase by the Company.  Prior to 2009 he has served as CEO of Respiratory Supply, Pinellas, Florida and Director of Business Development for Diabetic and Respiratory Supply of USA/CCS Medical, in Clearwater, Florida. Mark holds a BS degree in accounting and computer science from Troy State University, in Troy Alabama.

About Sanomedics International Holdings, Inc.

Sanomedics International Holdings, Inc. (SIMH) is a medical technology holding company that focuses on game changing products, services and ideas - a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. We plan to grow our existing business organically and through strategic acquisitions specifically relating to sleep disorder diagnosis treatments. Sanomedics seeks to acquire sleep therapy operating businesses and our strategy is to integrate a portfolio of world-class products and service providers in the growing Sleep Apnea market. Our goal is to provide Sleep Apnea patients with a reliable and integrated "end-to-end" service platform.

Forward Looking Statements
This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition of Prime Time is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

Contact: Keith Houlihan, 305-433-7814, keith@sanomedics.com


'/>"/>
SOURCE Sanomedics International Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. DSMs Marcel Lubben to Keynote SCD-iBIOs Second International Forum
2. SCD-iBIO Announces Second International Forum on Commercializing Global Green
3. iLab Solutions to Present SRA International Webinar for Research Administrators
4. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
5. RIAO/OPTILAS, ETOP Draw International Photonics Community to Portugal
6. Bayer CropScience Presents on Bee Health and Stewardship at International Pollinator Conference
7. Nerium International Names Krupp Kommunications, Inc. (K2) Public Relations Agency of Record
8. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
9. Dyadic International Reports Second Quarter 2013 Financial Results
10. Novus International to Present Scientific Findings on Prebiotics during Aquaculture Europe 2013
11. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks Associates ... will speak at the TMA 2017 Annual Meeting , October 11 ... in the residential home security market and how smart safety and security ... Parks Associates: ... "The residential security ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):